Published in Oncol Lett on April 11, 2017
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med (2012) 15.43
Esophageal cancer. N Engl J Med (2003) 15.23
Oesophageal carcinoma. Lancet (2013) 5.48
The tetraspanin superfamily: molecular facilitators. FASEB J (1997) 4.29
Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol (2003) 3.90
Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer (2002) 2.82
Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev (2004) 2.52
CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur J Immunol (1996) 2.10
Intracellular trafficking of lysosomal membrane proteins. Bioessays (1996) 2.09
Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell (1996) 1.94
Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J (2006) 1.93
Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res (1988) 1.72
Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation. Mol Cancer (2013) 1.56
Specific association of CD63 with the VLA-3 and VLA-6 integrins. J Biol Chem (1995) 1.52
Association of TM4SF proteins with integrins: relevance to cancer. Biochim Biophys Acta (1996) 1.51
Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer. Tumour Biol (2014) 1.39
Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int J Cancer (1995) 1.20
Outcomes after surgery for esophageal cancer. Gastrointest Cancer Res (2007) 1.18
TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression. Clin Exp Metastasis (2008) 1.14
Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol (1997) 1.10
CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma. Biochem Biophys Res Commun (1996) 1.05
CD63 associates with tyrosine kinase activity and CD11/CD18, and transmits an activation signal in neutrophils. J Immunol (1996) 1.04
Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View. Clin Endosc (2014) 1.02
Expression of the neuroglandular antigen and analogues in melanoma. CD9 expression appears inversely related to metastatic potential of melanoma. Int J Cancer (1993) 1.02
Tetraspanin CD63 promotes targeting and lysosomal proteolysis of membrane-type 1 matrix metalloproteinase. Biochem Biophys Res Commun (2003) 1.01
Identification of melanoma-associated antigens using fixed tissue screening of antibodies. Cancer Res (1984) 0.99
Expression of tetraspan protein CD63 activates protein-tyrosine kinase (PTK) and enhances the PTK-induced inhibition of ROMK channels. J Biol Chem (2008) 0.94
Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma. Cancer Res (2010) 0.93
N-linked glycan-dependent interaction of CD63 with CXCR4 at the Golgi apparatus induces downregulation of CXCR4. Microbiol Immunol (2009) 0.93
Complementary DNA arrays identify CD63 tetraspanin and alpha3 integrin chain as differentially expressed in low and high metastatic human colon carcinoma cells. Lab Invest (2002) 0.91
RPN2-mediated glycosylation of tetraspanin CD63 regulates breast cancer cell malignancy. Mol Cancer (2014) 0.88
Tetraspanin 1 promotes invasiveness of cervical cancer cells. Int J Oncol (2013) 0.88
Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trial. Am J Clin Oncol (2012) 0.87
Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells. Oncol Rep (2003) 0.87
A decrease in the expression of CD63 tetraspanin protein elevates invasive potential of human melanoma cells. Exp Mol Med (2003) 0.86
CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung. Lung Cancer (2007) 0.86
Tetraspanin CD63 acts as a pro-metastatic factor via β-catenin stabilization. Int J Cancer (2014) 0.82
Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas. Melanoma Res (1993) 0.80